Risk factor
Very poor trading liquidity
Profitability factor
Weak growth
About
PT Bundamedik Tbk provides health care services in Indonesia. As of December 31, 2021, the company operated 2 maternal and child hospitals, 3 general hospitals, 2 clinics, 10 IVF clinics, and 14 diagnostic laboratories. It also engages in the distribution of drugs, pharmaceuticals, and medical devices; and hotel, medical tourism, and management consulting businesses. The company was founded in 1973 and is headquartered in Jakarta Pusat, Indonesia. PT Bunda Medik is a subsidiary of PT Bunda Investama Indonesia.
Company Valuation
From both historical and forecast perspectives, the stock is fairly priced compared to similar stocks. In particular, the stock is overpriced on P/E, 'cheap' on EV/EBITD.
Target Price
The average target price of BMHS.JK is 220 and suggests 19% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to incr
Buy
Sell